THE WOODLANDS, Texas, July 2, 2018 /PRNewswire/ — RiceBran Technologies (NASDAQ: RIBT) (NASDAQ: RIBTW ) (“RBT”), a global leader in the production and marketing of value-added products derived from rice bran, announced today that the Company has received notification that the Food and Drug Administration (FDA) has granted RBT’s petition to consider rice bran fiber as a dietary fiber.
Ingredients containing two or more of the following cell wall fibers: cellulose, lignin; pectin; arabinoxylan and beta-glucan, in varying proportions fall within FDA’s broad category of ‘mixed plant cell wall fibers’ that the agency intends to include as dietary fibers. Rice bran fiber contains a mix of cellulose, arabinoxylan, lignin and pectin.
Robert Smith PhD, CEO & President of RiceBran Technologies commented, “We thank the FDA for all of the work they have put into reviewing the various petitions and are pleased that the agency has granted RBT’s petition to consider rice bran fiber as dietary fiber. This decision will allow companies the benefit of utilizing our rice bran as a source of dietary fiber for their products. We are excited to work with customers to help provide their consumers with a quality source of clean label rice bran ingredients containing dietary fiber, protein and oil.”
About RiceBran Technologies
RiceBran Technologies is a specialty ingredient company servicing the food, animal nutrition, and specialty ingredient products markets. We utilize our proprietary and patented intellectual property to convert rice bran, one of the world’s most underutilized food sources, into a number of highly nutritious and clean label ingredient products. The global target markets for our products include food and animal nutrition manufacturers and retailers, as well as specialty food, functional food and nutritional supplement manufacturers and retailers. More information can be found in the Company’s filings with the SEC and by visiting our website at https://www.ricebrantech.com.
This release contains forward-looking statements, including, but not limited to, statements about RiceBran Technologies’ expectations regarding future business resulting from the inclusion of rice bran on the FDA’s list of approved dietary fibers. RiceBran Technologies does not undertake to update forward-looking statements in this news release to reflect actual results, changes in assumptions or changes in other factors affecting such forward-looking information. Assumptions and other information that could cause results to differ from those set forth in the forward-looking information can be found in RiceBran Technologies’ filings with the Securities and Exchange Commission, including its most recent periodic reports.
Investor Relations Contact:
Ascendant Partners, LLC